4.6 Review

Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6

期刊

ALZHEIMERS RESEARCH & THERAPY
卷 13, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13195-021-00844-1

关键词

Subjective cognitive decline; Cognitive enhancement; Cognitive intervention; Mindfulness meditation; Physical training; Non-invasive brain stimulation; Drugs; Brain Health Service

资金

  1. Swiss National Science Foundation [IZSEZ0_193593]
  2. EU-EFPIA Innovative Medicines Initiatives 2 Joint Undertaking (IMI 2 JU) European Prevention of Alzheimer's Dementia consortium (EPAD) [115736]
  3. EU-EFPIA Innovative Medicines Initiatives 2 Joint Undertaking (IMI 2 JU) Amyloid Imaging to Prevent Alzheimer's Disease (AMYPAD) [115952]
  4. Swiss National Science Foundation: Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): correlation with clinical features and in vivo neuropathology [320030_182772]
  5. Swiss National Science Foundation (SNF) [IZSEZ0_193593] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

Cognitive complaints in the absence of objective cognitive impairment, observed in patients with subjective cognitive decline, are common in old age. Cognitive enhancement techniques, such as cognitive, mental, or physical training, have clinically relevant effects on cognitive and non-cognitive outcomes. Non-invasive brain stimulations show potential in improving memory performance, but more studies are needed to provide clear recommendations, while pharmacological cognitive enhancement drugs and herbal extracts do not have sufficient evidence to be recommended for individuals without cognitive impairment.
Cognitive complaints in the absence of objective cognitive impairment, observed in patients with subjective cognitive decline (SCD), are common in old age. The first step to postpone cognitive decline is to use techniques known to improve cognition, i.e., cognitive enhancement techniques. We aimed to provide clinical recommendations to improve cognitive performance in cognitively unimpaired individuals, by using cognitive, mental, or physical training (CMPT), non-invasive brain stimulations (NIBS), drugs, or nutrients. We made a systematic review of CMPT studies based on the GRADE method rating the strength of evidence. CMPT have clinically relevant effects on cognitive and non-cognitive outcomes. The quality of evidence supporting the improvement of outcomes following a CMPT was high for metamemory; moderate for executive functions, attention, global cognition, and generalization in daily life; and low for objective memory, subjective memory, motivation, mood, and quality of life, as well as a transfer to other cognitive functions. Regarding specific interventions, CMPT based on repeated practice (e.g., video games or mindfulness, but not physical training) improved attention and executive functions significantly, while CMPT based on strategic learning significantly improved objective memory. We found encouraging evidence supporting the potential effect of NIBS in improving memory performance, and reducing the perception of self-perceived memory decline in SCD. Yet, the high heterogeneity of stimulation protocols in the different studies prevent the issuing of clear-cut recommendations for implementation in a clinical setting. No conclusive argument was found to recommend any of the main pharmacological cognitive enhancement drugs (smart drugs, acetylcholinesterase inhibitors, memantine, antidepressant) or herbal extracts (Panax ginseng, Gingko biloba, and Bacopa monnieri) in people without cognitive impairment. Altogether, this systematic review provides evidence for CMPT to improve cognition, encouraging results for NIBS although more studies are needed, while it does not support the use of drugs or nutrients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据